5. data and comments. 5, page-67

re:5. media release--tanning drug. 5
http://stocknessmonster.com/news-item?S=EPT&E=ASX&N=217661

Extract:

“The problem is that many people have been using sunscreens under the assumption that they are protected from all forms of cancer-causing UV light,” said Dr Wayne Millen, Managing Director of EpiTan Limited, the company developing Melanotan.

“Many people have been taking in unhealthy levels of UVA light in the process. “Clearly, greater protection is needed in the fight against skin cancer, which is where Melanotan fits in. Melanotan stimulates the production of melanin in the skin, giving people a natural protective tan without prolonged sun exposure.

It gives people more protection for the time that they have to spend in the sun – just like wearing shirts and hats – and would be used in conjunction with other skin-protection methods.

Importantly, melanin does not discriminate against UVA and UVB light. It protects against both.” In the pivotal Phase II human trials, Melanotan was tested on 81 volunteers of varying skin types.

The results of the trial, released in November last year, were: • Sunburn injury was reduced by more than 50% in the fair- skinned volunteers who had Melanotan and who were subject to both UVA and UVB light • There was a highly-significant increase in skin melanin in Melanotan-treated volunteers • And fairer-skin volunteers recorded increases in melanin of up to 100% in some areas.---